If energy intake exceeds energy expenditure for a long period, obesity can result. A key factor in the regulation of energy intake is the sensation of satiety, and energy expenditure mainly occurs through basal metabolism, physical activity, thermoregulation, and the digestion and processing of ingested foods 1,2 . A highly complex system has evolved to control the balance between these two processes. This system is composed of several organs, including the liver, the pancreas, adipose tissues, the gastrointestinal tract and the brain. The peripheral tissues produce hormones and other signals in response to changes in feeding state and the size of the energy store of the body (adipose tissue). Examples of this include leptin produced in white adipocytes 3 , insulin produced in the pancreas 4 , ghrelin produced in the stomach [5] [6] [7] [8] , glucagon-like peptide 1 and PYY 3-36 produced in the intestine 9-11 and certain nutrients that are obtained from ingested food (for example, glucose, fatty acids and amino acids) [12] [13] [14] [15] . These signals are integrated by various neurons in the hypothalamus and brainstem, which then function to control food intake and energy expenditure [16] [17] [18] . Among these neurons, those carrying out the anorexigenic effect of the following three ligand-receptor pairs are particularly important: leptin and its receptor, α-melanocyte-stimulating hormone (αMSH) and one of its receptors the melanocortin 4 receptor (MC4R), and brain-derived neurotrophic factor (BDNF) and the tropomyosin receptor kinase B (TrkB).
. These signals are integrated by various neurons in the hypothalamus and brainstem, which then function to control food intake and energy expenditure [16] [17] [18] . Among these neurons, those carrying out the anorexigenic effect of the following three ligand-receptor pairs are particularly important: leptin and its receptor, α-melanocyte-stimulating hormone (αMSH) and one of its receptors the melanocortin 4 receptor (MC4R), and brain-derived neurotrophic factor (BDNF) and the tropomyosin receptor kinase B (TrkB).
Neurotrophic factors are well known for their promotion of neuronal differentiation and survival, axonal and dendritic growth, and synaptic formation and plasticity 19, 20 . In addition to BDNF, studies have implicated another neurotrophic factor, ciliary neurotrophic factor (CNTF), in the control of human body weight.
Mutations in the genes encoding BDNF and its receptor TrkB (encoded by NTRK2) lead to severe obesity in humans [21] [22] [23] [24] 
. Subcutaneous administration of recombinant CNTF has been found to reduce food intake and cause weight loss in obese humans 25 . In this Review, we focus on the evidence for BDNF and CNTF as regulators of satiety and body weight, we discuss the recent progress in our understanding of the neural basis of the anorexigenic effect of these two factors, and we present our opinions on the future directions of this research. We begin with a brief overview of the central mechanisms of energy balance regulation, focusing on the two well-studied signalling pathways, leptin and melano cortin, which are likely to interact with BDNF and CNTF to regulate body weight.
Intracerebroventricular infusion
Administration of chemicals or other reagents into the ventricular system of the brain.
Hypomorphic mice
Mutant mice in which the expression of a gene is reduced.
and ARH
AgRP neurons project to glutamatergic paraventricular hypothalamic MC4R-expressing neurons (PVH MC4R ), which in turn project to the lateral parabrachial nucleus (LPBN) to mediate the effect of MC4R on appetite 35, 37, 38 . By contrast, the projection of ARH POMC neurons to the MC4R-expressing sympathetic preganglionic neurons in the intermediolateral column (IML) of the spinal cord mediates the stimulatory effect of MC4R on energy expenditure 39 . Although leptin has been shown to regulate the gene expression and firing rate of both ARH POMC neurons and ARH AgRP neurons [40] [41] [42] , genetic evidence indicates that the effects of leptin on suppressing appetite and promoting energy expenditure are mainly mediated through its action on other neuronal types 43, 44 . Recent studies have shown that GABAergic RIP-Cre neurons in the ARH and hypothalamic neurons expressing nitric oxide synthase 1 (NOS1) mediate the effect of leptin on energy balance 45, 46 (FIG. 1b) . In the ARH, NOS1 neurons and RIPCre neurons are distinct from POMC neurons and AgRP neurons 45, 46 . ARH RIP-Cre neurons project to glutamatergic neurons in the ventral medial parvicellular part of the PVH (PVHmpv), which make connections with GABAergic neurons in the nucleus of the solitary tract (NTS). Leptin stimulates GABA release from ARH RIP-Cre neurons into the PVHmpv to promote thermogenesis in brown adipose tissue (BAT) 45 . NOS1 neurons are distributed in several brain areas, including the ARH and dorsomedial hypothalamus (DMH) 46 . Because leptin promotes satiety through GABAergic neurons 47 , it would be expected that the NOS1 neurons that afford leptin its anorexigenic activity would be GABAergic; however, their exact location remains to be determined.
BDNF: a key regulator of energy balance As discussed above, the induction of satiety and increased energy expenditure are two key regulators of overall energy balance, and BDNF seems to have a crucial role in both. The first clue that BDNF may be involved in the control of energy balance came from a study using chronic intracerebroventricular infusion of recombinant human BDNF, which was intended to examine the effect of BDNF on the function of cholinergic neurons but which instead was found to reduce the body weight of adult rats 48 . This weight loss resulted from appetite suppression and consequent decreased food intake 49 . This pharmacological discovery was corroborated by genetic evidence collected from several strains of mutant mice. Bdnf-heterozygous mice display increased body weight and mild hyperphagia 50, 51 . Furthermore, severe obesity is observed in hypomorphic mice that express TrkB at ~25% of normal levels 52 and in mice in which the Bdnf gene is deleted using a Cre transgene driven by the promoter for the α-isoform of Ca 2+ /calmodulin-dependent protein kinase II (CaMKIIα) 53 . Because CaMKIIα is a brain-specific protein 54 and the Camk2a-Cre transgene has not been reported to be active outside the brain (although transcripts derived from the Camk2a gene are present in peripheral tissues such as muscle 55 ), the latter two observations suggest that BDNF that is produced in the brain acts on the TrkB receptor to regulate energy balance.
If BDNF acts as a signal that regulates energy balance, its expression levels would be expected to change to reflect nutritional state (FIG. 1c) . Two-day food deprivation was found to drastically and selectively reduce levels of Bdnf mRNA in the mouse ventromedial hypothalamus (VMH) 52,56,57 . Furthermore, food deprivation was also found to reduce BDNF protein levels in the dorsal vagal complex (DVC) that contains the NTS and dorsal motor nucleus of the vagus (DMV), whereas refeeding or peripheral injection of the anorexigenic hormones leptin or cholecystokinin (CCK) increased BDNF protein levels in this area 58 , although it was not clear whether this regulation is at the level of transcription, translation or protein release. Melanocortin and glucose are likely to be key mediators that link energy status to Bdnf gene expression in the VMH, as administration of either a melanocortin analogue or glucose into fasted mice increased levels of Bdnf mRNA in the VMH 52, 56 . These gene expression data strongly support the idea that BDNF actively participates in the regulation of energy balance.
Neurons that produce BDNF to suppress appetite. As discussed above, food deprivation selectively and drastically reduces the levels of Bdnf mRNA in the mouse VMH 52, 56, 57 . This observation raises the possibility that VMH neurons produce BDNF to suppress appetite (FIG. 2) . Indeed, selective deletion of the Bdnf gene in the VMH and DMH of adult mice using adeno-associated virus (AAV)-expressing Cre recombinase caused modest hyperphagic obesity 56 . Because severe obesity was observed in mice in which the Bdnf gene was deleted in CaMKIIα-expressing neurons 53 or in which TrkB was downregulated in the whole body throughout life 52 , Box 1 | Obesity in humans with BDNF or NTRK2 mutations A de novo Y722C missense mutation in tropomyosin receptor kinase B (TrkB) was found in a boy with severe obesity and impairment in learning, memory and nociception 21 . Y722 is a key tyrosine residue in the activation loop of the TrkB kinase domain 80 , and this mutation markedly impairs the activation of the TrkB receptor 21 . Furthermore, a de novo mutation in a girl with hyperphagia and severe obesity was found to cause brain-derived neurotrophic factor (BDNF) haploinsufficiency 22 . Interestingly, one study showed that BDNF haploinsufficiency is the cause of hyperphagia and obesity associated with some patients with Wilms tumour, aniridia, genitourinary anomalies and mental retardation (WAGR) syndrome 24 . WAGR syndrome is a rare disorder that results from heterozygous, variably sized, contiguous deletions on chromosome 11, which extend into the BDNF gene in some cases 145 . Careful mapping of the deletion regions has linked BDNF haploinsufficiency to the accompanying obesity disorder 24 . These genetic studies clearly show that impairment in TrkB signalling does lead to obesity in humans; however, these mutations are rare and would not be substantial contributors to the high prevalence of obesity.
Single-nucleotide polymorphisms (SNPs) in the human BDNF gene could have a greater effect on the prevalence of human obesity than mutations in the BDNF and NTRK2 (which encodes TrkB) genes. Genome-wide association studies found several common SNPs in or near the BDNF gene to be associated with increased body mass index [146] [147] [148] [149] [150] [151] [152] [153] . One SNP (rs6265) is particularly interesting. This polymorphism occurs in the sequence encoding the pro-domain of the BDNF precursor, changes the Val residue at position 66 of preproBDNF to a Met residue (Val66Met), and impairs BDNF secretion via the regulated secretory pathway 154, 155 . A mouse strain that mimics the rs6265 polymorphism has been generated, and mice homozygous for the Val66Met substitution have significantly higher body weight than normal mice fed on a regular diet 156 , further supporting a role for rs6265 in human obesity. Nature Reviews | Neuroscience (FIG. 2) . The identification of these neurons makes it possible to determine where BDNF interacts with TrkB to regulate food intake in future studies.
Deletion of the Bdnf gene in the PVH during embryogenesis using the Sim1-Cre transgene 38 still caused hyperphagia and obesity; however, the phenotype was much less robust than that observed in mice in which the Bdnf gene was deleted in the adult PVH
60
. This phenomenon has been proposed to result from developmental compensation 60 . Because TrkB-hypomorphic mutant mice still develop marked hyperphagia and severe obesity even though TrkB expression is downregulated throughout the entire lifespan 52 , this compensation probably comes from the upregulation of BDNF in brain regions outside the PVH, rather than from increased activity of other anorexi genic signalling pathways. A similar compensation mechanism may explain why deleting the Bdnf gene in the adult VMH leads to modest obesity 56 , whereas deleting the Bdnf gene in the embryonic VMH using the Sf1-Cre transgene does not alter body weight 59 . These observations suggest that BDNF neurons in some brain structures (including the VMH) other than the PVH also have a role in the regulation of energy intake.
As BDNF is expressed in the DVC 62, 63 , one population of such BDNF neurons could be located in the DVC. It has been shown that nutritional state, leptin and CCK regulate levels of BDNF protein in the rat DVC 58 . Genetic studies are needed to determine the role of DVC BDNF in the control of food intake and energy balance.
BDNF and the regulation of energy expenditure Energy expenditure has several components, including basal metabolism rate, spontaneous physical activity, thermoregulation and exercise. Rodents produce heat Leptin simultaneously suppresses food intake by acting on NOS1 neurons in an undefined location. c | The locations of brain-derived neurotrophic factor (BDNF) neurons that sense nutritional state are shown. Glucose and anorexigenic factors, such as leptin, cholecystokinin (CCK) and α-melanocyte-stimulating hormone (αMSH), stimulate Bdnf gene expression in the ventromedial hypothalamus (VMH) and dorsal vagal complex that is comprised of the dorsal motor nucleus of the vagus (DMV) and NTS, suggesting that BDNF neurons in these two brain areas are involved in the control of food intake. It remains to be elucidated how BDNF that is produced in these neurons regulates food intake. DMH, dorsomedial hypothalamus; PVHa, anterior part of the PVH; PVHmpd, dorsal medial parvicellular part of the PVH; PVHp, posterior part of the PVH. through the β-oxidation of fatty acid in BAT to maintain body temperature, and BAT thermogenesis is a main component of energy expenditure in mice 1, 64 . Although it was initially thought that adult humans did not possess BAT, recent studies using new technologies such as positron emission tomography indicate a substantial amount of metabolically active BAT in humans 65 . The distribution of BAT deposits is similar between adult humans and rodents: a large BAT pad in the vicinity of the upper thorax, which is known as interscapular BAT (iBAT) in rodents, and small BAT pads on top of each of the sympathetic ganglia and near the adrenal gland 66 . This stereotypical localization of BAT deposits indicates that the regulation of thermogenesis is conserved from rodents to humans.
Sympathetic outflow increases the expression of uncoupling protein 1 (UCP1) in iBAT, which allows the energy generated from the β-oxidation of fatty acids to dissipate as heat in response to physiological and environmental stimuli such as overeating and cold temperatures by uncoupling the proton gradient from ATP synthesis in mitochondria 67, 68 . Both peripheral and central administration of BDNF were found to increase the turnover of noradrenaline, a neurotransmitter of sympathetic neurons, and Ucp1 gene expression in iBAT and to restore thermogenesis in food-deprived mice with a defective leptin receptor 69, 70 . Furthermore, the direct injection of BDNF into the hypothalamus in rats resulted in an increase in energy expenditure 71, 72 . These pharmacological studies suggest that BDNF is involved in the regulation of energy expenditure.
The genetic evidence for an important role for BDNF in regulating energy expenditure comes from a study of the PVH (FIG. 3) . Deletion of the Bdnf gene in the PVH with either the Sim1-Cre transgene or stereotaxic AAVCre injection led to reduced energy expenditure in mice by decreasing locomotor activity and impairing iBAT thermogenesis 60 . Trans-neuronal tract tracing studies using the pseudorabies virus have identified neurons in three PVH divisions that form polysynaptic connections with iBAT in rats: dorsal medial parvicellular part (PVHmpd), ventral medial parvicellular part (PVHmpv) and posterior part (PVHp) 73, 74 . Impressively, all neurons in the PVHmpd and PVHp that are connected to iBAT express BDNF in mice 60 . Furthermore, the vast majority of BDNF neurons in these two PVH divisions send axons to the spinal cord 60 . These observations suggest that BDNF neurons in the PVHmpd and PVHp release BDNF at their axonal terminals to support sympathetic preganglionic neurons in the IML of the spinal cord, which control iBAT metabolism through sympathetic postganglionic neurons in the stellate ganglion. In support of this idea, sympathetic preganglionic neurons in the IML were found to express TrkB and become atrophic when the Bdnf gene was deleted in the PVH 60 . Thus, BDNF neurons in the anterior PVH promote locomotor activity, whereas those in the medial and posterior PVH drive iBAT thermogenesis through the PVH-IML-stellate ganglion-iBAT neural circuit.
The observation that PVH BDNF neurons have a role in regulating energy expenditure does not contradict reports that hyperphagia is the cause of obesity in several Bdnf mutant mouse strains. Pair feeding, which restricts mutant mice to consuming the same amount of food as wild-type mice, was found to correct excessive weight gain in Bdnf-heterozygous mice 75 , in conditional knockout mice in which the Bdnf gene was selectively deleted in the DMH and VMH 56 , and in mice lacking the long isoform of Bdnf mRNA 76 . However, Bdnf-heterozygous mice show increased locomotor activity 50 , which may compensate for reduced BAT thermogenesis. The DMH/VMH-BDNF-conditional knockout mice should still have normal BDNF expression in the PVH to drive iBAT thermogenesis and to promote locomotor activity; neurons also produce a short form of Bdnf mRNA 77 and BDNF derived from this short form of Bdnf mRNA in the PVH may be sufficient to regulate BAT thermogenesis and locomotor activity. In support of this argument, young mice that lack the long form of Bdnf mRNA have normal expression of thermogenic genes in iBAT and the sympathetic preganglionic neurons in the IML are of normal size 60 . The PVHmpv neurons have been shown to receive innervation from GABAergic RIP-Cre neurons in the ARH and to project to the NTS to stimulate BAT thermogenesis 45 . This ARH RIP-Cre neuron-PVHmpv-NTS neural circuit and the PVH BDNF neuron-IML neural circuit may have distinct roles in the control of BAT thermogenesis. Disruption of the ARH RIP-Cre neuron-PVHmpv-NTS circuit impairs BAT thermogenesis in response to highfat diet ingestion 45 but the PVH BDNF neuron-IML circuit is not required for BAT thermogenesis in response to 
Adaptive thermogenesis
A process by which brown adipose tissues enhance the combustion of fatty acids into heat in response to physiological and environmental stimuli such as cold.
high-fat diet ingestion, although it is essential for BAT thermogenesis in response to cold exposure 60, 78 . Studies are needed to address how these two neural circuits interact with each other to regulate adaptive thermogenesis.
In addition to the PVH, BDNF that is expressed in other brain regions may also have a role in the control of energy expenditure. For example, BDNF injection into the VMH has been found to increase energy expenditure by promoting locomotor activity in rats 71 ; environmental enrichment has been thought to induce the browning of white adipocytes by stimulating Bdnf gene expression in the hypothalamus 79 . It remains to be determined which neurons produce BDNF to mediate these effects.
TrkB neurons in energy balance regulation BDNF exerts its biological effects through two receptors, p75
NTR and TrkB
80
. Mutations in the gene encoding TrkB, but not in the gene encoding p75 NTR , lead to obesity in humans and mice 21, 52, 81 , suggesting that the effects of BDNF on energy balance are mediated via the TrkB receptor. There are four modes by which BDNF that is produced in a neuron can reach TrkB-expressing neurons [82] [83] [84] : being released and binding to TrkB on the same neuron (autocrine) or on neighbour neurons (paracrine); being anterogradely transported to the axonal terminals of the neuron and released to bind TrkB on targeted neurons (anterograde); and being retrogradely transported to cell bodies of innervating neurons following release and binding to TrkB at axonal terminals (retrograde).
Therefore, BDNF may act on TrkB neurons that are either near or far away from the cell bodies of its producing neurons to regulate energy balance. The binding of BDNF to TrkB activates several intracellular signalling cascades
, but no studies have yet been conducted to determine which signalling cascades are required for the BDNF regulation of energy balance.
TrkB neurons in several brain structures have been implicated in the control of energy balance. As expected, these structures include several hypothalamic nuclei such as ARH, VMH and PVH 72, [85] [86] [87] [88] [89] [90] . In addition, some evidence has indicated that TrkB neurons in the nucleus accumbens and NTS are also involved in regulating energy balance 91, 92 . The ARH is situated in close proximity to the bottom of the third ventricle and is an important brain region that senses circulating factors that reflect the state of feeding and energy store 17 . It contains at least three neuronal populations on the basis of the expression of three markers: POMC, AgRP and RIP-Cre. The ARH also expresses TrkB, and the majority of ARH TrkB neurons are distinct from these three neuronal populations 87 . Some ARH TrkB neurons are activated in response to either fasting or refeeding after fasting 87 , indicating that these neurons may have a role in the control of food intake. It is necessary to further evaluate the role of ARH TrkB neurons in the control of energy balance by deleting the Ntrk2 gene or by altering the activity of these neurons.
If ARH TrkB neurons do regulate food intake, they may do so by projecting to PVH BDNF neurons (FIG. 2) . This view is supported by the observation that the axonal number of ARH neurons is significantly reduced in the PVH of mutant mice that lack the long form of Bdnf mRNA and that display marked hyperphagia 76, 87 . It has been shown that the long form of Bdnf mRNA is transported to dendrites for local translation 93 . Thus, a mutant mouse that lacks the long form of Bdnf mRNA would not synthesize BDNF in dendrites. Because dendritically synthesized BDNF is released from dendrites, this could be the mechanism by which ARH TrkB neurons, which innervate dendrites of PVH BDNF neurons, achieve their potential effect on food intake.
It is worth noting that one study has shown that although the central administration of TrkB agonists (BDNF, NT4 or a TrkB antibody agonist) is anorexigenic in non-human primates, similar to what has been observed in rodents, peripheral administration is orexigenic, which is opposite to what has been observed in rodents 94 . Peripherally administered TrkB agonists are likely to act on ARH TrkB neurons to affect food intake, because the blood-brain barrier is more permeable in the region of the ARH. It is possible that some ARH TrkB neurons may promote feeding when the TrkB is activated. Peripherally administered TrkB agonists could preferentially act on these orexigenic neurons in nonhuman primates, but mainly act on anorexigenic ARH TrkB neurons in rodents, owing to anatomical differences between the two species.
Direct injection of BDNF into either the VMH or the PVH of adult rats decreased food intake and increased energy expenditure 71, 72, 85, 86 . One study suggests that 
Hedonic feeding
Consuming food to obtain pleasure in the absence of an energy deficit.
Signal peptide
A short peptide of 5-30 amino acids in length at the amino terminus of a newly synthesized protein that is destined for the plasma membrane or to be secreted from the cell.
BDNF suppresses feeding in the VMH by increasing cell-surface expression of a thrombospondin receptor, which enhances the function of excitatory synapses 89 . Delivery of BDNF into the medial NTS of the brainstem also reduced food intake and increased thermogenesis, and these effects could be blocked using a TrkB antagonist 95 . These results suggest that TrkB in these three brain areas is important for the control of energy balance. However, genetic evidence is still needed to demonstrate that endogenous BDNF-TrkB signalling in each of these brain regions is involved in the control of energy balance.
In addition to the ARH, VMH, PVH and NTS, BDNF may also act on TrkB neurons in other brain regions to exert homeostatic regulation of feeding and energy expenditure. It has become clear that neuronal compositions in each hypothalamic or hindbrain nucleus, such as the ARH 87 and PVH 60 , are complex. It is reasonable to consider that TrkB neurons in each of these nuclei are connected to multiple neural circuits. Once a brain region is confirmed as a BDNF action site, the next challenge is to map the neural circuits that are the basis of BDNF-regulated energy balance. This information is essential to understand where BDNF interacts with TrkB and how BDNF modulates the activity of the neural circuit in response to changes in feeding state and energy store.
BDNF and hedonic eating
In addition to its role in the homeostatic regulation of energy balance, BDNF may suppress hedonic feeding of palatable food through the reward system, which begins in the ventral tegmental area (VTA) and connects to the nucleus accumbens 96 . Mice with deficient BDNF-TrkB signalling had much worse hyperphagia when being fed on high-fat diets than when they were fed on low-fat diets 52, 91, 97 , which is attributed to increased meal size 97 . Mice lacking BDNF synthesis in CaMKIIα-expressing neurons displayed hypersensitivity of the dopamine receptor D 1 , such that peripheral injection of a D 1 receptor agonist normalized the hyperphagia observed with high-fat diets 91 . The effect of BDNF deficiency on the dopamine receptor D 1 could be a compensatory response to decreased stimulated release of dopamine in the nucleus accumbens and the dorsal striatum. As the VTA has been identified as an important source of BDNF that contributes to the regulation of hedonic eating 91 , it would be interesting to determine whether BDNF acts on TrkB-expressing neurons in the VTA or the nucleus accumbens to regulate the consumption of palatable food. It is crucial to understand the changes in the structure and function of the reward circuit when BDNF signalling is impaired and leads to hyperphagia on a high-fat diet, as excessive intake of a high-fat diet is likely to be an important cause of human obesity.
CNTF CNTF was identified as a survival factor for parasympathetic neurons that were isolated from the chick ciliary ganglion 98, 99 . It is sequestered within the cytoplasm, probably due to the lack of a signal peptide 100 . Owing to its intracellular localization 98, 99 , CNTF is regarded as a lesion factor rather than as a target-derived neurotrophic factor 101 . Indeed, CNTF is a key player in injury response in the nervous system. Lesions in the brain Nature Reviews | Neuroscience The binding of brain-derived neurotrophic factor (BDNF) to tropomyosin receptor kinase B (TrkB) receptors causes receptor dimerization, which leads to the activation of their tyrosine kinase and phosphorylation of the tyrosine residues located in their intracellular domains (see the figure) . Some of the phosphorylated tyrosine residues serve as the docking sites of signalling molecules such as SHC and phospholipase Cγ1 (PLCγ1). Recruitment of these signalling molecules triggers the activation of various intracellular signalling pathways, such as those mediated by MAPK, phosphatidylinositol 3-kinase (PI3K) and PLCγ1. Activation of the RAS-RAF-MAPK/ERK kinase (MEK)-mitogen-activated protein kinase (MAPK) signalling cascade promotes neuronal differentiation and maturation, whereas activation of the PI3K-AKT signalling cascade is essential for neuronal survival 80 . In addition, the MAPK and PI3K signalling cascades increase translation by phosphorylating eukaryotic initiation factor 4E (eIF4E), 4E-binding protein (4E-BP) and ribosomal protein S6 kinase (S6K), which have an important role in the regulation of protein synthesisdependent synaptic plasticity 157 . Activated PLCγ1 hydrolyses phosphatidylinositol-4,5-bisphosphate to produce diacylglycerol (DAG), which can activate protein kinase C (PKC), and inositol-1,4,5-trisphosphate (IP3), which leads to Ca 2+ release from intracellular stores. Activation of PKC-and Ca
2+
-regulated pathways can enhance synaptic plasticity 80 . It is unknown which signalling cascades are required for the BDNF regulation of energy balance. Because synaptic plasticity is important to the regulation of energy balance 132, 133 and because BDNF is a potent regulator of synaptic plasticity in multiple brain regions 158, 159 , it is plausible to speculate that BDNF regulates energy balance by modulating synaptic plasticity of neuronal circuits in the hypothalamus and brainstem.
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Amyotrophic lateral sclerosis
A nervous system disease that is often known as Lou Gehrig's disease, which causes muscle weakness and affects physical function.
Cachectic
Having cachexia that is characterized by loss of appetite, loss of weight, muscle atrophy, fatigue and weakness.
cause a substantial increase in both CNTF mRNA and protein levels 102, 103 . However, application of CNTF prevented the degeneration of motor neurons after axotomy 101 and promoted the survival of hippocampal neurons in culture 104 . Furthermore, disruption of the Cntf gene led to motor neuron degeneration, demonstrating its physiological role in the maintenance of motor neurons 105 .
CNTF signalling cascades. Cell injury will release intracellular CNTF. Upon binding to a receptor complex that is composed of CNTF receptor-α (CNTFRα), leukaemia inhibitory factor receptor-β (LIFRβ) and glycoprotein 130 (gp130) on the cell surface, CNTF activates one signalling cascade that involves the Janus tyrosine kinase-signal transducers and activators of transcription (JAK-STAT) and another signalling cascade that involves RAS and mitogen-activated protein kinase (MAPK) [106] [107] [108] [109] [110] (FIG. 4) . CNTFRα lacks a transmembrane domain and is tethered to the plasma membrane via a glycosylphosphatidylinositol linkage 106 . The activated CNTF receptor complex phosphorylates STAT3 and STAT1, leading to either homodimerization or heterodimerization of these proteins, and their subsequent nuclear translocation to induce gene expression 111 . The activation of MAPK temporally follows STAT activation 107 . It involves the recruitment of Src homology 2 phosphatase (SHP2) to phosphorylated gp130, the interaction of SHP2 with membrane-associated RAS and the subsequent activation of MAPK by RAS 112, 113 . Activated MAPK can downregulate STAT transcriptional activity by suppressing its tyrosine phosphorylation 114 , thus serving as a negative feedback mechanism. In addition, one study found that CNTF could interact with its receptor complex in the nucleus to activate the aforementioned signalling pathways 115 , which may explain the neuronal survival activity of endogenous CNTF that lacks a signal peptide. However, this interesting observation needs to be confirmed, given that neither CNTF nor its receptor components contains a nucleus localization signal.
Weight loss induced by CNTF administration. Because CNTF can promote the survival of motor neurons 101, 105 , it has been tested as a therapeutic agent for amyotrophic lateral sclerosis. In clinical trials, treatment with CNTF induced unexpected and dramatic weight loss in obese human patients, and this weight loss persisted after the cessation of treatment 116, 117 . Similarly, systemic administration of recombinant CNTF suppressed food intake and decreased body weight in leptin-deficient ob/ob mice and in mice with diet-induced obesity (DIO) 118 . Given that CNTF levels are acutely elevated in response to neuronal injury, CNTF may exert its substantial weight loss effect in a similar way to cachectic cytokines. Indeed, it was reported that CNTF possessed inflammatory properties 119 and that its administration triggered inflammatory responses, including fever 120 . A study designed to address this issue found that efficacious doses of recombinant CNTF reduced food intake and body weight in ob/ob mice and DIO mice without inducing cachectic responses such as muscle wasting, pro-inflammatory gene expression, conditioned taste aversion and corticosterone release 121 . Therefore, CNTF is mostly likely to induce weight loss by promoting satiety. The ability of CNTF to induce weight loss in obese humans and in leptin-resistant DIO mice gives rise to the hope that CNTF could be developed into a therapeutic agent for obesity treatment, although a clinical trial using Axokine (Regeneron), a modified human CNTF with improved stability and potency, as an obesity therapy failed owing to the development of neutralizing antibodies to the drug.
So far, there has been no strong evidence to implicate endogenous CNTF signalling in the control of energy balance. Neither obesity nor hyperphagia has been reported in Cntf −/− mice 105 , Cntfra −/− mice 122 or humans with CNTF . However, deletion of either the Cntf gene or the Cntfra gene throughout the body leads to the loss of motor neurons 105, 122 , which may impair feeding and thus block the development of hyperphagia and obesity. A conclusive demonstration of the physiological role of CNTF in the control of energy balance may need to come from the selective ablation of CNTF signalling in the hypothalamus.
Mechanisms underlying the CNTF regulation of body weight. There are some similarities between leptin signalling and CNTF signalling in the brain. First, the leptin receptor is closely related to the LIF receptor and gp130 in the CNTF receptor complex 106, 124 . Second, CNTF and leptin activate overlapping signalling molecules, particularly the STAT3 transcription factor [125] [126] [127] . It has been shown that STAT3 activation is required for leptin regulation of energy balance 128 . Third, the CNTF receptors and the leptin receptor have overlapping distributions in some hypothalamic nuclei that are involved in the control of feeding, such as the ARH and PVH 129, 130 . These similarities raise the possibility that CNTF acts on leptin-responsive neurons to regulate satiety and body weight. However, one study found that deleting the Cntfra gene in cells expressing the leptin receptor did not diminish the anorectic effect of exogenous CNTF treatment 131 . This genetic finding demonstrates that CNTF and leptin regulate energy balance by activating similar signalling cascades but in distinct neuronal populations.
Neuronal plasticity in the hypothalamus is important in the regulation of energy balance. Synaptic density in ARH POMC and ARH AgRP neurons in ob/ob mice rapidly changes in response to leptin administration before the anorexigenic effect is detected 132 . Furthermore, hunger induces synaptogenesis of excitatory synapses in ARH AgRP neurons, as indicated by an increase in the number of dendritic spines in the neurons of fasted mice 133 . Adult neurogenesis is also a form of neuronal plasticity by changing neuronal density and composition in a brain region. Central administration of CNTF was found to promote cell proliferation in the adult mouse hypothalamus. Many of these new-born cells express neuronal markers and can respond to leptin. Moreover, killing the new-born cells blocks the long-term, but not the shortterm, effects of CNTF on body weight 134 . These observations suggest that CNTF might suppress food intake partly by stimulating adult neurogenesis in the hypothalamus.
Interaction with leptin and MC4R pathways Leptin-leptin receptor, αMSH-MC4R and BDNF-TrkB are arguably the most important ligand-receptor pairs in the central control of energy balance, because deficits in any of these three signalling pathways lead to severe obesity in both humans 21, 24, [135] [136] [137] and mice 3, 52, 53, 124, 138, 139 . It is plausible to expect that the BDNF-TrkB pathway interacts with the other two pathways in the control of feeding and energy expenditure.
Studies have shown that BDNF interacts with MC4R signalling in both the hypothalamus and the brainstem to regulate energy balance. Activation of MC4R stimulated the expression of BDNF in the VMH 52 and BDNF release from rat hypothalamus explants 140 , suggesting that BDNF regulates energy balance downstream of MC4R. In support of this view, BDNF infusion into the lateral ventricle attenuated hyperphagia and excessive weight gain in mice with decreased MC4R activity 52 . Similarly, simultaneous administration of BDNF reversed hyperphagia induced by an MC4R antagonist infused into the fourth ventricle 141 . Furthermore, BDNF that was delivered directly into the medial NTS reduced food intake, which was reversed by pretreatment with a TrkB antagonist 95 , whereas acute blockade of TrkB activation abolished the anorexigenic effect of MC4R agonists in the brainstem 141 . There are several possible reasons why the anorexigenic effect of MC4R in the brainstem is dependent on TrkB activation. First, TrkB activation could be essential to keeping a neural circuit functional, thereby providing a permissive condition for the action of MC4R. Second, the signalling cascades that are activated by the two receptors may interact with each other inside neurons. Third, TrkB and MC4R may act on two distinct but interdependent neural circuits to suppress food intake. Delineation of the neural circuits that mediate the anorexigenic effect of the two receptors in the brainstem will help to answer this question.
Much less is known about the interaction between the BDNF-TrkB pathway and the leptin system. Very few BDNF neurons express the leptin receptor in the hypothalamus 76 , and it is unlikely that leptin would directly regulate BDNF gene expression in this brain area. However, leptin is able to increase neuronal excitability, for example, in ARH POMC neurons 41 , which can in turn alter BDNF gene expression. In addition, leptin has been shown to increase dendritic BDNF synthesis in cultured hypothalamic neurons through increases in neuronal activity 76 . Furthermore, some TrkB neurons in the hypothalamus express the leptin receptor 87 . The co-expression of the two receptors could also occur in the DVC, because co-administration of a selective TrkB antagonist into the medial NTS was found to attenuate the suppressive effect of leptin on food intake in rats 92 . It would be interesting to investigate whether there is crosstalk between the signalling cascades activated by TrkB and the leptin receptor.
Although CNTF treatment causes marked weight loss, its connection to the leptin and melanocortin systems remains to be defined. Some CNTF-induced adult-born neurons in the ARH express POMC and are responsive to leptin 134 . Furthermore, CNTF was found to stimulate Pomc gene expression in the ARH 115, 142 . Therefore, CNTF treatment should increase the activity of the leptin and melanocortin systems.
Perspectives
Evidence from both genetic and pharmacological studies has demonstrated that BDNF has a vital role in the control of energy balance by promoting satiety and energy expenditure. Case studies have clearly shown that impairment in TrkB signalling or BDNF haploinsuf ficiency causes severe hyperphagia and obesity in humans. This type of mutation is very rare, and it is still unclear what role TrkB signalling impairment has in the obesity of the general population. The current obesity problem is likely to be related to the consumption of calorie-dense food. It is important to investigate whether alterations in TrkB signalling contribute to diet-induced obesity.
As discussed above, researchers have begun to identify the neurons that produce BDNF and the neurons that BDNF acts on to regulate energy balance. Identification of these neurons and their connected neural circuits will make it possible to investigate how BDNF regulates the function of these neural circuits. It would be interesting to know whether BDNF modulates synaptic plasticity in these circuits as it does at hippocampal synapses. Because a deficit in TrkB signalling leads to extreme hyperphagia in both mice and humans, activation of these neural circuits should exert powerful suppression on the appetite. Studies on the composition and regulation of these neural circuits will not only increase our understanding of the central control of feeding behaviour but may also reveal a way to manipulate the activity of these circuits. Pharmacological activation of the neural circuits could be an effective way to combat the obesity problem.
In contrast to BDNF, evidence is still lacking to implicate endogenous CNTF in the control of energy balance. This evidence may come from future studies examining the change of CNTF signalling in DIO and the effect of region-specific ablation of CNTF signalling in the brain on energy balance. In rodent DIO models, exposure to high-fat diets increases the expression of pro-inflammatory cytokine genes, such as the genes encoding interleukin-1β, interleukin-6 and tumour necrosis factor, in the hypothalamus 143, 144 . It would be interesting to examine whether high-fat diet feeding leads to changes in the gene expression of CNTF and its receptors in the hypothalamus. Region-specific mouse mutants will bypass the complication of motor neuron degeneration that is caused by the general ablation of CNTF signalling. Even if endogenous CNTF signalling is not involved in the control of energy balance, it is still valuable to elucidate the molecular and neural mechanisms by which CNTF treatment induces drastic and lasting weight loss in leptin-resistant obese humans and mice. The mechanisms could be used to develop novel interventions for obesity.
